News

Candel Therapeutics' Significant Updates Ahead of Medical Meeting

Candel Therapeutics' Significant Updates Ahead of Medical Meeting

Candel Therapeutics Makes Mark at Upcoming Medical Conference

Candel Therapeutics, Inc. (Candel or the Company) (NASDAQ: CADL), a clinical-stage biopharmaceutical company, is making waves with its groundbreaking research in cancer immunotherapy. The Company will showcase its innovative enLIGHTEN™ Discovery Platform, coupled with compelling data from the CAN-2409 (aglatimagene besadenovec) program focusing on non-small cell lung cancer (NSCLC), through poster presentations at the Society for Immunotherapy of Cancer's (SITC) 40th Anniversary Annual Meeting.

Key Presentations Highlighting Innovations in Cancer Therapy

Candel will present two posters showcasing their advancements in the field of cancer treatment, demonstrating their commitment to providing innovative solutions to tackle daunting health challenges. This engaging event, set to take place over several days, offers a platform for experts in the field to discuss novel immunotherapy approaches.

Poster Presentations

The first poster presentation titled 'Integrative discovery of a multimodal cancer immunotherapy using machine learning and viral vector engineering' will delve into the intersection of technology and medicine. Dr. Anne Diers, the Vice President of Research at Candel Therapeutics, will lead the presentation, highlighting significant study findings and the potential impact on cancer treatment protocols.

The second poster, presented by Dr. Daniel H. Sterman from NYU Langone Medical Center, will explore an 'Advanced analytics identify a differential immune response to CAN-2409+valacyclovir in non-squamous vs squamous NSCLC, linked to improved survival in patients with progressive ICI-refractory NSCLC'. This pivotal research provides insights into how tailored therapies can enhance patient outcomes in challenging cancer cases.

Engaging Discussions on Cancer Immunotherapy

As part of the event, Dr. Paul Peter Tak, the President and CEO of Candel Therapeutics, will discuss the promising results from the Phase 3 clinical trial of CAN-2409. The presentation will focus on combining CAN-2409 with standard care radiation therapy for the treatment of newly diagnosed localized prostate cancer. This renowned panel is expected to address pivotal themes in cancer immunotherapy, exploring both the potential and challenges facing the development of the next generation of cancer therapeutics.

About Candel Therapeutics

Candel is dedicated to pioneering effective cancer therapies through innovative research in multimodal biological immunotherapies. Their primary platform revolves around advanced therapeutic approaches using genetically modified adenovirus and herpes simplex virus constructs. Currently, CAN-2409 stands as a frontrunner in their portfolio, showcasing promising results from recent trials. The Company’s strategic focus has generated excitement as they aim to address various cancers, including non-small cell lung cancer and pancreatic ductal adenocarcinoma.

Innovative Therapies Leading the Way

Candel Therapeutics is also advancing another notable product candidate, CAN-3110 (linoserpaturev), which is undergoing a phase 1b clinical trial in patients with recurrent high-grade glioma. Utilizing an innovative approach, CAN-3110 has garnered attention due to its distinct mechanism and promising initial results. The continuous commitment to research and development places Candel in a pivotal position to contribute significantly to the cancer therapy landscape.

The enLIGHTEN™ Discovery Platform, a vital component of their research, exemplifies their strength in utilizing human biology and advanced data analytics to create innovative therapies tailored for solid tumors. This systematic approach not only enhances their research capabilities but also positions Candel as a key player in the biopharmaceutical sector.

Investor and Media Relations

Candel Therapeutics recognizes the importance of keeping communication channels open. Interested parties can reach out to Theodore Jenkins, Vice President of Investor Relations, and Ben Shannon for media inquiries. Their proactive stance on investor and media relations reflects their dedication to transparency and engagement.

Frequently Asked Questions

What is the focus of Candel Therapeutics?

Candel Therapeutics focuses on developing multimodal biological immunotherapies aimed at helping patients fight cancer.

What products are highlighted at the SITC meeting?

The Company will present data on CAN-2409 for non-small cell lung cancer and localized prostate cancer, as well as insights from their enLIGHTEN™ Discovery Platform.

Who presents at the SITC Annual Meeting on behalf of Candel?

Dr. Paul Peter Tak, M.D., Ph.D., FMedSci, the President and CEO of Candel Therapeutics, will lead a presentation at the event.

What is CAN-3110?

CAN-3110 is another product candidate from Candel's HSV platform, currently in an ongoing phase 1b clinical trial for recurrent high-grade glioma.

How can investors and media contact Candel Therapeutics?

Investors can reach Theodore Jenkins at tjenkins@candeltx.com, and media inquiries can be directed to Ben Shannon at CandelPR@icrhealthcare.com.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Decoding CarBravo-Certified vs Traditional Used Cars

Updated Category News Views 21

What’s Behind Door Number One: CarBravo Certification When you walk onto a car lot these days, it's a mixed bag: shiny badges boasting certifications or basic used car signage. For anyone who's spent time around cars, two types stick out—there’s your CarBravo-certified vehicles and your good ol' used cars. Now, Marissa McCoy and Jill Maniaci from Heidebreicht...

Continue Reading
OCI N.V. Secures a Win in Court; EGM Proceeds as Planned

Updated Category News Views 24

OCI Dodges a Bullet in Amsterdam Court Stepping into the courtroom drama, OCI N.V. just took home a win as the Amsterdam Court of Appeal's Enterprise Chamber gave them a clean bill of health, kicking out the inquiry request from VEB and a bunch of other shareholders. The judges weren't convinced there was anything fishy going on, so they tossed the inquiry petition and...

Continue Reading
HelloNation Brings 'Edvertising' to NC REALTORS® Event

Updated Category News Views 25

HelloNation's Bold Step into Real Estate Networking October 8th to the 11th is shaping up to be a pivotal few days in Wilmington, North Carolina. Here’s the scoop: HelloNation, known for its innovative 'edvertising' model, is joining the bustling crowd at the 2026 NC REALTORS® Convention. This isn’t just any get-together—it's the grandest annual jamboree for real...

Continue Reading
C3EL Expands Federal Footprint with Strategic Contracts

Updated Category News Views 9

Pushing Boundaries in Federal Contracts What a ride C3EL's had in Government Fiscal Year 2026! Let me tell you, they’ve bagged a bunch of contracts that’d make any company’s mouth water. Kicking things off, they snagged a prime cybersecurity contract from the U.S. Air Force. Considering our current cybersecurity landscape, that's like striking gold. But they...

Continue Reading
Wally Disrupts Dental Industry with $25M Funding

Updated Category News Views 24

A New Breath of Fresh Air for Dental Care Dental visits—a tedious, costly affair we've all dreaded. So, when Wally rolls out an overhaul in this stale landscape, it's worth taking notice. With $25 million in their pockets from Series A funding led by Maveron, Wally's swaggering in with a plan to flip the script on dental care across the nation. Redefining the Dental...

Continue Reading
Duke Energy's Cost-Protection Plan Shields Ratepayers

Updated Category News Views 18

Shielding Customers From Data Center Costs Let's get right into the thick of it: Duke Energy's latest move is a strategic one, shrouded in industry terms but with a real impact on regular folks' wallets. The company's agreement with heavyweights like Amazon, Google, and Meta aims to protect existing customers in North Carolina from getting hit with the costs of powering...

Continue Reading
Gong, Agentforce, Avoma Crowned 2026 CI Champions

Updated Category News Views 23

Diving Deep into Conversation Intelligence There's a lot to unpack when three software titans hog the spotlight, and that's exactly what's happening in the world of conversation intelligence this year. It's like we've hit the jackpot with Gong, Agentforce Sales, and Avoma carving out their turf as the 2026 Champions, according to the venerable Info-Tech Research Group....

Continue Reading
EMCO's New Automated Facility Could Shake Industry

Updated Category News Views 22

A Novel Leap in Production Capacity EMCO Industries just put a solid foot on the accelerator with their brand-new, shiny, fully automated plant over in Claremore, Oklahoma. If you're glancing at heavy-duty trailer springs, you can't ignore the fact that this is a multimillion-dollar investment. Heck, this monstrous 30,000-square-foot facility more than doubles what EMCO...

Continue Reading
Ornellaia's 2026 Harvest: Adapting to Nature's Whims

Updated Category News Views 14

A Year Marked by Weather's Unpredictable Dance Nobody said making wine was a walk in the park, and the folks at Ornellaia know better than most how to roll with whatever nature throws their way. The 2026 harvest story is as much about unlocking the secrets of the soil as it is about navigating the quirks of the weather. Situated in Bolgheri, Italy, this year's vintage...

Continue Reading
U. of Phoenix and LACCD Launch 3+1 Degree Pathway

Updated Category News Views 15

Opening the Floodgates for Ambitious Community College Students When it comes to climbing the educational ladder, not everyone starts at the same rung. That's a fact we've all come to terms with in one way or another. Enter the University of Phoenix and the Los Angeles Community College District with a solution to expand educational access. The 3+1 Program: A Cost-Saving...

Continue Reading

Top 5 Most Recently Viewed Articles

Tonal 2 Revolutionizes Home Fitness with Innovative Design

Updated Category News Views 762

Tonal 2 Revolutionizes Home Fitness Experience Tonal, recognized for pioneering the world’s most intelligent strength training system, is thrilled to introduce Tonal 2. This innovative home fitness solution is meticulously designed to enhance performance and expedite muscle building. Outfitted with a stunning all-black finish and chic chrome accents, Tonal 2 not only...

Continue Reading
Innovative MEMS Probe Card Enhances Semiconductor Testing

Updated Category News Views 214

Transforming Semiconductor Testing with MEMS Technology STAr Technologies, a prominent name in the probe card manufacturing landscape, has recently introduced its latest innovation, the STAr Virgo Prima. This advanced probe card not only exemplifies 25 years of expertise but also represents a significant leap forward in the realm of semiconductor testing. Designed...

Continue Reading
Wyndham Hotels & Resorts Earnings Call Announcement and Insights

Updated Category News Views 180

Wyndham Hotels & Resorts to Report Second Quarter Earnings Wyndham Hotels & Resorts (NYSE: WH) is set to announce its second quarter results, promising insights into their performance and future strategies. This announcement is of particular interest to investors and travelers alike, as it underscores the company's significant role in the global hospitality industry....

Continue Reading
Strategic Leadership Changes at Hankook Tire Boost Growth

Updated Category News Views 376

Strategic Leadership Changes at Hankook Tire Boost Growth Hankook Tire & Technology, a leading tire manufacturer, has recently announced several key executive leadership updates within its North American sales and marketing team. These changes are designed to strengthen their operations and ensure the company's growth trajectory continues in the competitive tire market....

Continue Reading
Senate Hearing on Semiconductor Use in Russian Military

Updated Category News Views 49

Senate Panel to Discuss Semiconductor Manufacturers The U.S. Senate Permanent Subcommittee on Investigations is preparing for an important hearing that will examine the role of American semiconductor companies in relation to Russian military applications. This hearing is a direct response to discoveries that American-made semiconductors have been found in weapons...

Continue Reading